Solid Tumour Oncogenesis

Oncogene amplifications have been shown in solid human cancers and they are often associated with progression of cancer. Defining oncogene amplification is useful since it is used as a prognostic marker in clinical oncology nowadays, especially v-erb-b2 avian erythroblastic leukemia viral oncogene homolog 2 (HER2) targeted agents are used in breast cancer patients with high level of HER2 overexpression as a therapeutic approach.

    Related Conference of Solid Tumour Oncogenesis

    June 15-16, 2026

    10th Global Meeting on Oncology and Radiology

    Paris, France
    June 22-23, 2026

    16th World Congress on Breast Cancer

    Dubai, UAE
    June 23-24, 2026

    27th World Congress on Cancer Summit

    Paris, France
    July 27-28, 2026

    6th World Congress on Breast Cancer

    Rome, Italy
    September 28-29, 2026

    36th Experts Meet On Cancer Research & Therapy

    Aix-en-Provence, France
    October 05-06, 2026

    22nd International Conference on Cancer Research

    Madrid, Spain
    November 19-20, 2026

    44th World Cancer Conference

    Dubai, UAE
    November 23-24, 2026

    7th Cancer Diagnostics & Treatment Conference

    Miami, USA
    November 23-24, 2026

    8th International Conference on Women Oncology

    Miami, USA
    December 08-09, 2026

    14th Euro Breast Cancer and Therapeutics

    Paris, France

    Solid Tumour Oncogenesis Conference Speakers

      Recommended Sessions

      Related Journals

      Are you interested in